1. GATA6 loss-of-function mutation contributes to congenital bicuspid aortic valve
- Author
-
Ri-Tai Huang, Xiu-Mei Li, Song Xue, Ruo-Min Di, Juan Wang, Xing-Yuan Liu, Qi Qiao, Ying-Jia Xu, and Yi-Qing Yang
- Subjects
Adult ,Male ,0301 basic medicine ,Proband ,endocrine system ,Adolescent ,Genetic counseling ,Nonsense mutation ,Heart Valve Diseases ,Biology ,Young Adult ,03 medical and health sciences ,Bicuspid aortic valve ,Bicuspid Aortic Valve Disease ,GATA6 Transcription Factor ,Genetics ,medicine ,Humans ,Genetic Predisposition to Disease ,GATA6 ,Genetic heterogeneity ,GATA4 ,Sequence Analysis, DNA ,General Medicine ,Middle Aged ,medicine.disease ,Pedigree ,HEK293 Cells ,030104 developmental biology ,Codon, Nonsense ,Aortic Valve ,Case-Control Studies ,Mutation (genetic algorithm) ,Female - Abstract
Congenital bicuspid aortic valve (BAV), the most common form of birth defect in humans, is associated with substantial morbidity and mortality. Increasing evidence demonstrates that genetic risk factors play a key role in the pathogenesis of BAV. However, BAV is a genetically heterogeneous disease and the genetic determinants underpinning BAV in an overwhelming majority of patients remain unknown. In the present study, the coding exons and flanking introns of the GATA6 gene, which encodes a zinc-finger transcription factor essential for the normal development of the aortic valves, were sequenced in 152 unrelated patients with congenital BAV. The available relatives of a proband harboring an identified GATA6 mutation and 200 unrelated, ethnically matched healthy individuals used as controls were also genotyped for GATA6. The functional characteristics of the mutation were analyzed by using a dual-luciferase reporter assay system. As a result, a novel heterozygous GATA6 mutation, p.E386X, was identified in a family with BAV transmitted in an autosomal dominant mode. The nonsense mutation was absent in 400 control chromosomes. Biological assays revealed that the mutant GATA6 protein had no transcriptional activity compared with its wild-type counterpart. Furthermore, the mutation disrupted the synergistic transcriptional activation between GATA6 and GATA4, another transcription factor causally linked to BAV. In conclusion, this study firstly associates GATA6 loss-of-function mutation with enhanced susceptibility to familial BAV, which provides novel insight into the molecular mechanism of BAV, implying potential implications for genetic counseling and personalized management of BAV patients.
- Published
- 2018